Rare diseases
Investigational molecules
Locations
Ul. Aleje Raclawickie 1, 20-059 Lublin, Poland
Clinical research in myasthenia gravis focuses on treatment strategies for autoimmune weakness and fatigability, with interest in therapies that modify disease activity and improve functional outcomes.
The sponsor is active in therapeutic evaluation for chronic autoimmune neuromuscular disease, reflecting engagement with conditions requiring long-term clinical management.
Uniwersytet Medyczny W Lublinie runs clinical trials in conditions such as Chronic lymphocytic leukaemia, Chronic lymphocytic leukaemia recurrent, Lichen sclerosus, Lichenoid keratosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Clobetasol, Mometasone, and Tacrolimus for Treating Vulvar Lichen Sclerosus in Children
PolandStudy of venetoclax plus rituximab in adult patients with relapsed chronic lymphocytic leukemia (CLL) in Poland
PolandSafety and efficacy of venetoclax, obinutuzumab and daratumumab in adult patients with relapsed chronic lymphocytic leukemia
PolandStudy on Bevacizumab Dose Equivalence for Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer Using Bevacizumab, Olaparib, Carboplatin, and Paclitaxel
PolandStudy on Cladribine for Treating Seropositive Myasthenia Gravis in Patients
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
